We determined the frequencies of CD1c+ mDCs and CD304+ pDCs in both the blood and LN tissue of healthy controls (HCs), RA-risk individuals and early-RA patients by flow cytometry. This evidence concerns the gene NRP1 and rheumatoid arthritis.